Review of the laboratory approaches to the detection of antibody and cell-mediated immunity to pertussis disease and vaccine

Expert Review of Vaccines

Volumn 13, Issue 10, 2014, Pages 1183-1190

  Edwards, Kathryn M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cell mediated immunity; CHO cell neutralization; ELISA; micro agglutination; pertussis

Indexed keywords

ACELLULAR VACCINE; ANTIBODY; CYTOKINE; HUMORAL ANTIBODY; PERTUSSIS TOXIN; PERTUSSIS VACCINE; BACTERIUM ANTIBODY;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; LABORATORY TEST; MEMORY CELL; MITOGENESIS; NONHUMAN; PERTUSSIS; REVIEW; SEROLOGY; VACCINATION; WHOLE CELL; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY;

ANIMALS; ANTIBODIES, BACTERIAL; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 84905974899     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.946015     Document Type: Review

References (35)

1. Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995;96:548-57
2. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995;96:570-5
3. Cattaneo LA, Reed GW, Haase DH, et al. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996;173(5):1256-9
4. Steketee RW, Burstyn DG, Wassilak SG, et al. A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis 1988; 157(3):441-9
5. Cherry JD, Chang SJ, Klein D, et al. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults. Clin Infect Dis 2004;39(11):1715-18
6. de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000;38(2): 800-6
7. Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004;11(6):1045-53
8. Giammanco A, Chiarini A, Maple PA, et al. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 2003;8:22(1):112-20
9. Giammanco A, Nardone A, Pebody R, et al. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine 2008; 18:26(35):4486-93
10. Xing D, Wirsing von König CH, Newland P, et al. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin Vaccine Immunol 2009;16(3):303-11
11. He Q, Barkoff AM, Mertsola J, European Bordetella expert group (EUpertstrain); European surveillance network for vaccine-preventable diseases (EUVAC.NET). High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance. Euro Surveill 2012;17:32
12. Xing D, Markey K, Newland P, et al. EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis. J Immunol Methods 2011;372(1-2):137-45
13. Kapasi A, Meade BD, Plikaytis B, et al. Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays. Clin Vaccine Immunol 2012;19(1): 64-72
14. Prelog M, Almanzar G, Rieber N, et al. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine 2013;31(2):387-93
15. Barkoff AM, Gröndahl-Yli-Hannuksela K, Vuononvirta J, et al. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Vaccine 2012;30(48): 6897-902
16. Gillenius P, Jäätmaa E, Askelöf P, et al. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J Biol Stand 1985;13(1):61-6
17. Isacson J. Studies of pertussis epidemiology. and of serum antibody responses to Bordetella pertussis antigens after disease and vaccination. Doctoral Thesis, Department of Pediatrics; SU/Ö strasjukhuset, Goteborg University, Sweden
18. Dalby T, Sørensen C, Petersen JW, Krogfelt KA. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay. APMIS 2010;118(12): 968-72
19. Blumberg DA, Pineda E, Cherry JD, et al. The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis - strain dependent. Am J Dis Child 1992;146(10):1148-50
20. Guiso N, Berbers G, Fry NK, EU Pertstrain group. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 2011;30(3):307-12
21. Mink CM, O'Brien CH, Wassilak S, et al. Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect Immun 1994;62(3):1118-20
22. Meade BD, Lynn F, Reed GF, et al. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics 1995; 96(3 Pt 2):595-600
23. Cassone A, Ausiello CM, Urbani F, et al. The Progetto Pertosse-CMI Working Group. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch Pediatr Adolesc Med 1997;151:283-9
24. Ausiello CM, Urbani F, la Sala A, et al. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997;65:2168-74
25. Dirix V, Verscheure V, Goetghebuer T, et al. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Vaccine 2009;27(43):6042-7
26. Smits K, Pottier G, Smet J, et al. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Vaccine 2013;32(1):111-18
27. Schure RM, Hendrikx LH, de Rond LG, et al. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children. Clin Vaccine Immunol 2012;19:1879-86
28. Schure RM, de Rond L, Oztürk K, et al. Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age. PLoS One 2012;7(7):e41928
29. Vaughan K, Seymour E, Peters B, Sette A. Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Hum Immunol 2014;75(5):440-51
30. Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th edition. Elsevier Incorporated; Philadelphia, PA, USA: 2013. p. 447-92
31. Miller JJ SR, Saito TM. An agglutinative reaction for Haemophilus pertussis, II: its relations to clinical immunity. J Pediatr 1943;22:644-51
32. Sako W. Studies on pertussis immunization. J Pediatr 1947;30:29-40
33. Medical Research Council. Vaccination against whooping cough: final report to Whooping Cough Immunization Committee. Br Med J 1959;1:994-1000
34. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998;16(20):1907-16
35. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16(20):1901-6